UNICYCIVE THERAPEUTICS, INC. Gain (Loss) on Extinguishment of Debt
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Gain (Loss) on Extinguishment of Debt of $19.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-31
- UNICYCIVE THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- UNICYCIVE THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- UNICYCIVE THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was $0.00.
- UNICYCIVE THERAPEUTICS, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was $19.00K.
- UNICYCIVE THERAPEUTICS, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $19.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $19.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $19.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $19.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $19.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |